“…It has been shown to be safe and adequate in inducing sustainable and important weight loss [2], and it is also recommended for the treatment of comorbid diseases, including diabetes mellitus, hypertension, sleep apnea, and degenerative joint disease [2,3]. As part of the workup for bariatric surgery, most surgeons have long advocated routine preoperative Helicobacter pylori (H. pylori) testing and, if necessary, eradication therapy [1,[4][5][6][7][8][9][10]. The prevalence of the infection in patients undergoing weight-loss surgery is reported to be 24% to 67% [1,4,[11][12][13].…”